Literature DB >> 11591156

Studies of the mechanism of phenol hydroxylase: mutants Tyr289Phe, Asp54Asn, and Arg281Met.

D Xu1, D P Ballou, V Massey.   

Abstract

Three residues in the active site of the flavoprotein phenol hydroxylase (PHHY) were independently changed by site-directed mutagenesis. One of the mutant forms of PHHY, Tyr289Phe, is reduced by NADPH much slower than is the wild-type enzyme, although it has a slightly higher redox potential than the wild-type enzyme. In the structure of the wild-type enzyme, residue Tyr289 is hydrogen-bonded with the FAD when the latter is at the "out" position but has no direct contact with the flavin when it is "in". The oxidative half-reaction of PHHY is not significantly affected by this mutation, contrary to the concept that Tyr289 is a critical residue in the hydroxylation reaction [Enroth, C., Neujahr, H., Schneider, G., and Lindqvist, Y. (1998) Structure 6, 605-617; Ridder, L., Mullholland, A. J., Rietjens, I. M. C. M., and Vervoort, J. (2000) J. Am. Chem. Soc. 122, 8728-8738]. Tyr289 may help stabilize the FAD in the out conformation where it can be reduced by NADPH. For the Asp54Asn mutant form of PHHY, the initial step of the oxidative half-reaction is significantly slower than for the wild-type enzyme. Asp54Asn utilizes less than 20% of the reduced flavin for hydroxylating the substrate with the remainder forming H(2)O(2). Similar changes are observed when Arg281, a residue between Asp54 and the solvent, is mutated to Met. These two residues are suggested to be part of the active site environment the enzyme provides for the flavin cofactor to function optimally in the oxidative half-reaction. In the construction of the mutant forms of PHHY, it was determined that 11 of the previously reported amino acid residues in the sequence of PHHY were incorrect.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591156     DOI: 10.1021/bi010962y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Structure and ligand binding properties of the epoxidase component of styrene monooxygenase .

Authors:  Uchechi E Ukaegbu; Auric Kantz; Michelle Beaton; George T Gassner; Amy C Rosenzweig
Journal:  Biochemistry       Date:  2010-03-02       Impact factor: 3.162

2.  Isolation of cytoplasmic NADPH-dependent phenol hydroxylase and catechol-1,2-dioxygenase from Candida tropicalis yeast.

Authors:  Lenka Vilímková; Jan Páca; Veronika Kremláčková; Jan Páca; Marie Stiborová
Journal:  Interdiscip Toxicol       Date:  2008-12

3.  Altering toluene 4-monooxygenase by active-site engineering for the synthesis of 3-methoxycatechol, methoxyhydroquinone, and methylhydroquinone.

Authors:  Ying Tao; Ayelet Fishman; William E Bentley; Thomas K Wood
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

4.  Kinetic mechanism of ornithine hydroxylase (PvdA) from Pseudomonas aeruginosa: substrate triggering of O2 addition but not flavin reduction.

Authors:  Kathleen M Meneely; Eric W Barr; J Martin Bollinger; Audrey L Lamb
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

5.  The substrate-bound crystal structure of a Baeyer-Villiger monooxygenase exhibits a Criegee-like conformation.

Authors:  Brahm J Yachnin; Tara Sprules; Michelle B McEvoy; Peter C K Lau; Albert M Berghuis
Journal:  J Am Chem Soc       Date:  2012-04-27       Impact factor: 15.419

6.  Catalytic Control of Spiroketal Formation in Rubromycin Polyketide Biosynthesis.

Authors:  Marina Toplak; Raspudin Saleem-Batcha; Jörn Piel; Robin Teufel
Journal:  Angew Chem Int Ed Engl       Date:  2021-11-10       Impact factor: 16.823

7.  A radical intermediate in the conversion of pentachlorophenol to tetrachlorohydroquinone by Sphingobium chlorophenolicum.

Authors:  Johannes Rudolph; Annette H Erbse; Linda S Behlen; Shelley D Copley
Journal:  Biochemistry       Date:  2014-10-06       Impact factor: 3.162

Review 8.  Form follows function: structural and catalytic variation in the class a flavoprotein monooxygenases.

Authors:  Karen Crozier-Reabe; Graham R Moran
Journal:  Int J Mol Sci       Date:  2012-11-23       Impact factor: 5.923

Review 9.  Limitations and lessons in the use of X-ray structural information in drug design.

Authors:  Andrew M Davis; Stephen A St-Gallay; Gerard J Kleywegt
Journal:  Drug Discov Today       Date:  2008-08-27       Impact factor: 7.851

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.